Vijay Chiruvolu
Chief Tech/Sci/R&D Officer at TURNSTONE BIOLOGICS CORP.
Profile
Vijay Chiruvolu is currently the Chief Technology Officer at Turnstone Biologics Corp.
Prior to this, he was the Chief Technical Officer at Instil Bio, Inc. from 2020 to 2022.
He also held the position of Senior Vice President-Process Development at Kite Pharma, Inc. Dr. Chiruvolu holds an MBA from The Pennsylvania State University and a doctorate from The University of Nebraska-Lincoln.
Vijay Chiruvolu active positions
| Companies | Position | Start |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Chief Tech/Sci/R&D Officer | 28/02/2023 |
Former positions of Vijay Chiruvolu
| Companies | Position | End |
|---|---|---|
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 01/09/2022 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Training of Vijay Chiruvolu
| The Pennsylvania State University | Masters Business Admin |
| The University of Nebraska-Lincoln | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Vijay Chiruvolu
